| Literature DB >> 23954700 |
M Marshall1, G Peat, E Nicholls, D van der Windt, H Myers, K Dziedzic.
Abstract
OBJECTIVE: To compare the population prevalence, inter-relationships, risk factor profiles and clinical characteristics of subsets of symptomatic hand osteoarthritis (OA) with a view to understanding their relative frequency and distinctiveness.Entities:
Keywords: Epidemiology; Erosive OA; Hand osteoarthritis; Nodal OA; Subsets; Thumb base OA
Mesh:
Year: 2013 PMID: 23954700 PMCID: PMC3819994 DOI: 10.1016/j.joca.2013.08.004
Source DB: PubMed Journal: Osteoarthritis Cartilage ISSN: 1063-4584 Impact factor: 6.576
Population prevalence estimates of symptomatic hand OA subsets stratified by gender and age
| Phenotypes | Erosive OA | Generalised hand OA | Thumb base OA | IPJ OA | Nodal IPJ OA | Non-nodal IPJ OA | |
|---|---|---|---|---|---|---|---|
| Definition | E/R phase ≥2 IPJs (rays 2–5) across either hand | K&L ≥ 2 in ≥1 DIPJ & ≥1 PIPJ & ≥1 first CMCJ across either hand | K&L ≥ 2 in first CMCJ in either hand | K&L ≥ 2 in ≥2 IPJs (rays 2–5) across either hand | K&L ≥ 2 in ≥2 IPJs (rays 2–5) & ≥2 HN or BN (rays 2–3) across either hand | K&L ≥ 2 in ≥2 IPJs (rays 2–5) & <2 HN or BN (rays 2–3) across either hand | |
| Men: | |||||||
| 50–54 | 506 | 9.8 (4.5, 15.2) | 8.1 (4.1, 12.2) | 4.7 (1.2, 8.2) | 3.4 (0.3, 6.6) | ||
| 55–59 | 695 | 2.9 (0.4, 5.4) | 11.3 (7.3, 15.4) | 9.6 (5.4, 13.7) | 6.1 (2.8, 9.4) | 3.5 (0.8, 6.3) | |
| 60–64 | 566 | 5.1 (2.4, 7.9) | 16.8 (12.6, 21.0) | 15.9 (10.8, 21.0) | 9.1 (5.2, 13.0) | 6.8 (3.4, 10.1) | |
| 65–69 | 434 | 0.6 (−0.5, 1.7) | 8.5 (4.5, 12.6) | 18.8 (13.1, 24.6) | 18.7 (13.6, 23.7) | 11.2 (7.2, 15.2) | 7.5 (4.0, 11.0) |
| 70–74 | 323 | 8.8 (3.4, 14.3) | 21.6 (15.0, 28.2) | 18.3 (11.9, 24.8) | 11.3 (4.7, 17.8) | 7.1 (3.0, 11.2) | |
| 75–79 | 238 | 10.9 (4.6, 17.1) | 21.8 (13.7, 30.0) | 20.1 (12.5, 27.6) | 14.0 (7.0, 21.0) | 6.1 (1.9, 10.3) | |
| 80+ | 211 | 16.2 (8.2, 24.2) | 27.4 (18.3, 36.4) | 25.4 (16.0, 34.7) | 19.8 (9.4, 30.3) | 5.5 (−0.3, 11.4) | |
| Women: | |||||||
| 50–54 | 539 | 0.9 (−0.3, 2.1) | 4.4 (1.3, 7.5) | 16.2 (10.9, 21.6) | 12.9 (7.4, 18.4) | 9.8 (4.9, 14.7) | 3.1 (0.3, 5.9) |
| 55–59 | 694 | 1.1 (−0.1, 2.2) | 8.6 (5.2, 12.1) | 21.7 (16.7, 26.6) | 18.9 (14.0, 23.8) | 14.9 (10.3, 19.6) | 4.0 (1.4, 6.5) |
| 60–64 | 517 | 1.5 (−0.0, 3.0) | 9.5 (5.6, 13.5) | 24.7 (18.8, 30.5) | 22.8 (17.8, 27.8) | 18.9 (14.1, 23.6) | 3.9 (1.6, 6.2) |
| 65–69 | 442 | 1.8 (0.2, 3.4) | 15.1 (10.4, 19.7) | 30.0 (24.4, 35.6) | 29.5 (23.8, 35.3) | 24.7 (19.3, 30.1) | 4.8 (1.8, 7.8) |
| 70–74 | 402 | 3.2 (0.8, 5.6) | 20.8 (14.7, 26.8) | 34.4 (28.2, 40.5) | 32.4 (25.5, 39.2) | 27.4 (20.9, 33.8) | 5.0 (1.9, 8.0) |
| 75–79 | 319 | 2.4 (0.0, 4.8) | 22.0 (14.7, 29.4) | 36.7 (29.5, 44.0) | 34.1 (26.8, 41.4) | 28.9 (21.6, 36.2) | 5.2 (1.1, 9.2) |
| 80+ | 420 | 2.2 (−0.2, 4.6) | 28.1 (20.0, 36.2) | 39.8 (31.7, 47.9) | 36.9 (29.2, 44.6) | 32.0 (23.8, 40.2) | 4.9 (−0.1, 9.9) |
Population prevalence estimates were calculated from CASHA study participants. Figures are percentages (95% CI) unless otherwise specified.
IPJ OA (includes nodal IPJ OA and non-nodal IPJ OA).
Negative lower CIs are due to imputation of data.
Estimate could not be calculated as no participants were classified as having the subset in one or more imputed dataset; E/R, eroded or remodelled phase according to Verbruggen & Veys scoring method; DIPJ, Distal Interphalangeal Joint; PIPJ, Proximal Interphalangeal Joint; HN, Heberden node; BN, Bouchard node.
Fig. 1Classification of mutually exclusive groups (n = 1076).
Fig. 2Area-proportional Venn diagram showing the relative frequency and overlap of hand OA subsets in a symptomatic population (n = 1076).
Descriptive characteristics of the symptomatic hand OA subsets (n = 1076)
| Overall | Unclassified | Erosive OA | Generalised hand OA | IPJ and thumb base OA | Thumb base OA | Nodal IPJ OA | Non-nodal IPJ OA | |
|---|---|---|---|---|---|---|---|---|
| Frequency in study population % (no.) | 100% (1076) | 35.3% (380) | 4.8% (52) | 15.2% (164) | 9.0% (97) | 22.5% (242) | 7.6% (82) | 5.5% (59) |
| Age, mean (s.d.) | 64.8 (8.3) | 60.9 (7.4) | 70.1 (8.1) | 69.6 (8.0) | 67.2 (7.0) | 65.1 (8.2) | 65.3 (7.1) | 65.5 (8.1) |
| % Female (no.) | 60.4% (650) | 52.9% (201) | 82.7% (43) | 73.2% (120) | 67.0% (65) | 55.0% (133) | 63.4% (52) | 61.0% (36) |
| BMI, mean (s.d.) | 29.1 (5.1) | 29.2 (4.9) | 28.7 (4.9) | 29.2 (5.2) | 29.5 (5.3) | 28.8 (5.0) | 30.0 (6.1) | 28.6 (4.4) |
| % Manual occupational class (no.) | 53.5% (540) | 58.0% (206) | 54.3% (25) | 51.6% (81) | 48.9% (44) | 48.2% (109) | 51.2% (41) | 61.8% (34) |
| % Attended higher education (no.) | 15.9% (167) | 14.0% (52) | 17.6% (9) | 14.6% (23) | 23.4% (22) | 16.0% (38) | 14.6% (12) | 18.6% (11) |
| % Pain on most or all days in the last month (no.) | 43.6% (469) | 35.8% (136) | 55.8% (29) | 45.7% (75) | 44.3% (43) | 49.6% (120) | 50.0% (41) | 42.4% (25) |
| % Radiographic hand OA (K&L ≥ 2 in ≥2 joints) (no.) | 61.9% (666) | 7.4% (28) | 100.0% (52) | 100.0% (164) | 100.0% (97) | 76.0% (184) | 100.0% (82) | 100.0% (59) |
| Number of joints K&L ≥ 2 (0–20), mean (s.d.) | 3.7 (4.1) | 0.4 (0.7) | 12.2 (4.1) | 9.0 (3.7) | 5.5 (1.6) | 2.3 (1.1) | 5.0 (3.1) | 4.3 (2.2) |
| Number of joints K&L ≥ 3 (0–20), mean (s.d.) | 1.4 (2.6) | <0.1 (0.2) | 8.8 (4.1) | 2.8 (3.0) | 2.0 (2.0) | 0.8 (0.9) | 1.1 (1.6) | 0.8 (1.4) |
| Number of joints K&L = 4 (0–20), mean (s.d.) | 0.6 (1.6) | <0.1 (0.1) | 5.3 (3.4) | 1.1 (1.7) | 0.7 (1.3) | 0.3 (0.6) | 0.4 (0.8) | 0.1 (0.4) |
| Total K&L score (0–80), mean (s.d.) | 10.8 (11.8) | 1.8 (2.2) | 39.8 (14.0) | 23.8 (10.3) | 15.4 (5.8) | 7.0 (3.4) | 13.4 (7.2) | 11.4 (6.3) |
| % Symptomatic radiographic knee OA (no.) | 58.3% (595) | 56.4% (207) | 54.2% (26) | 65.6% (103) | 66.7% (60) | 54.6% (125) | 60.0% (45) | 52.7% (29) |
| % Symptomatic moderate–severe radiographic knee OA (no.) | 29.3% (302) | 20.2% (74) | 37.5% (18) | 41.4% (65) | 40.0% (36) | 31.4% (72) | 30.7% (23) | 25.5% (14) |
Analysis was completed on CASHA and CASK study participants using mutually exclusive subsets as determined in Fig. 1.
Individuals in this sub-group are symptomatic with pain in the last month and may have some radiographic changes, but they do not meet the criteria for any of the hand OA subsets.
Symptomatic radiographic knee OA is knee pain in the last month and radiographic OA of tibiofemoral or patella–femoral joints of either knee (K&L ≥ 2 on PA and/or skyline views and/or posterior or lateral osteophytes ≥1 on lateral view).
Symptomatic moderate–severe radiographic knee OA is knee pain in the last month and moderate to severe radiographic OA of tibiofemoral or patella–femoral joints of either knee (K&L ≥ 3 on PA and/or skyline views and/or posterior or lateral osteophytes ≥3 on lateral view); s.d., standard deviation; data was missing for the following characteristics: BMI n = 2 (0.3%), manual occupational class n = 67 (6.2%), attended higher education n = 23 (2.1%), symptomatic radiographic knee OA n = 55 (5.1%) and symptomatic moderate–severe radiographic knee OA n = 55 (5.1%).
Risk of selected exposures for subsets of symptomatic hand OA (n = 1076)
| Unclassified | Erosive OA | Generalised hand OA | IPJ and thumb base OA | Thumb base OA | Nodal IPJ OA | Non-nodal IPJ OA | Likelihood ratio chi-square test | ||
|---|---|---|---|---|---|---|---|---|---|
| Previous hand injury | % (no.) | 28.8% (88) | 32.0% (16) | 24.8% (36) | 37.8% (31) | 34.1% (71) | 31.6% (24) | 31.4% (16) | |
| aRRR (95% CI) | 1 | 1.5 (0.7, 2.9) | 0.9 (0.6, 1.5) | 1.7 (1.0, 2.9) | 1.3 (0.9, 1.9) | 1.2 (0.7, 2.1) | 1.2 (0.6, 2.2) | ||
| Excessive use of hands in employment or pastimes | % (no.) | 81.1% (258) | 84.0% (42) | 79.0% (120) | 86.9% (73) | 82.7% (177) | 85.5% (65) | 80.8% (42) | |
| aRRR (95% CI) | 1 | 1.7 (0.7, 4.0) | 1.1 (0.7, 2.0) | 1.9 (0.9, 3.9) | 1.2 (0.8, 2.0) | 1.6 (0.8, 3.2) | 1.1 (0.5, 2.3) | ||
| BMI >30 kg/m2 | % (no.) | 37.5% (142) | 42.3% (22) | 39.0% (64) | 34.0% (33) | 33.9% (82) | 40.7% (33) | 37.3% (22) | |
| aRRR (95% CI) | 1 | 1.2 (0.7, 2.3) | 1.1 (0.7, 1.6) | 0.9 (0.5, 1.4) | 0.9 (0.6, 1.2) | 1.1 (0.7, 1.9) | 1.0 (0.6, 1.8) | ||
| Diabetes/IFG | % (no.) | 6.3% (24) | 9.6% (5) | 13.4% (22) | 9.3% (9) | 7.0% (17) | 11.0% (9) | 5.1% (3) | |
| aRRR (95% CI) | 1 | 1.3 (0.4, 3.6) | 1.7 (0.9, 3.4) | 1.2 (0.5, 2.7) | 0.9 (0.5, 1.7) | 1.5 (0.7, 3.4) | 0.6 (0.2, 2.2) | ||
| Hypertension | % (no.) | 26.3% (100) | 48.1% (25) | 40.9% (67) | 28.9% (28) | 35.1% (85) | 25.6% (21) | 32.2% (19) | |
| aRRR (95% CI) | 1 | 1.7 (0.9, 3.2) | 1.3 (0.9, 2.0) | 0.9 (0.5, 1.4) | 1.3 (0.9, 1.8) | 0.8 (0.5, 1.4) | 1.1 (0.6, 2.0) | ||
| Dyslipidaemia | % (no.) | 21.1% (80) | 30.8% (16) | 20.1% (33) | 22.7% (22) | 25.2% (61) | 14.6% (12) | 23.7% (14) | |
| aRRR (95% CI) | 1 | 1.8 (0.9, 3.6) | 1.0 (0.6, 1.6) | 1.1 (0.6, 1.8) | 1.1 (0.8, 1.7) | 0.6 (0.3, 1.2) | 1.1 (0.6, 2.1) | ||
| Metabolic syndrome | % (no.) | 7.4% (28) | 15.4% (8) | 10.4% (17) | 7.2% (7) | 8.3% (20) | 6.2% (5) | 5.1% (3) | |
| aRRR (95% CI) | 1 | 1.7 (0.7, 4.1) | 1.1 (0.5, 2.2) | 0.8 (0.3, 1.8) | 0.9 (0.5, 1.7) | 0.7 (0.2, 1.8) | 0.5 (0.2, 1.9) |
Analysis was completed on CASHA and CASK study participants using mutually exclusive subsets as determined in Fig. 1; Likelihood ratio chi-square test indicates (overall) whether model fit was improved by having the risk factor in the model, statistical significance all of models were calculated to six degrees of freedom.
Individuals in this sub-group are symptomatic with pain in the last month and may have some radiographic changes, but they do not meet the criteria for any of the hand OA subsets.
Defined as three or more of the following factors: i) BMI >30 kg/m2, ii) diagnosis by general practitioner of diabetes or IFG, iii) hypertension, iv) dyslipidaemia (elevated triglycerides or cholesterol) or prescription of a lipid-regulating drug; aRRR, age/sex adjusted relative risk ratios; data was missing for the following exposures: previous hand injury n = 158 (14.7%), excessive use of hand in employment or pastimes n = 130 (12.1%), BMI >30 kg/m2n = 2 (0.2%) and metabolic syndrome n = 2 (0.2%).
Clinical characteristics at baseline of the symptomatic hand OA subsets (n = 1076)
| Unclassified | Erosive OA | Generalised hand OA | IPJ and thumb base OA | Thumb base OA | Nodal IPJ OA | Non-nodal IPJ OA | Difference between the groups (ANOVA) significance | |
|---|---|---|---|---|---|---|---|---|
| AUSCAN Pain (0–20), mean (95% CI) | 6.3 (5.9, 6.8) | 7.6 (6.4, 8.7) | 7.0 (6.4, 7.7) | 6.6 (5.7, 7.5) | 6.7 (6.1, 7.3) | 6.9 (6.0, 7.8) | 6.7 (5.6, 7.8) | |
| AUSCAN Function (0–36), mean (95% CI) | 9.4 (8.5, 10.3) | 13.3 (11.1, 15.5) | 11.7 (10.4, 12.9) | 10.4 (8.6, 12.1) | 10.8 (9.7, 11.9) | 10.1 (8.4, 11.9) | 9.9 (7.8, 12.0) | |
| Grip strength in lbs., mean (95% CI) | 59.1 (56.5, 61.8) | 35.6 (28.6, 42.6) | 45.0 (41.1, 49.0) | 47.6 (42.4, 52.8) | 52.3 (49.1, 55.6) | 49.3 (43.7, 54.9) | 54.5 (47.9, 61.1) | |
| Pinch strength in lbs., mean (95% CI) | 11.8 (11.7, 12.2) | 8.2 (7.1, 9.3) | 9.6 (8.9, 10.2) | 9.7 (8.9, 10.5) | 10.4 (9.9, 10.9) | 10.5 (9.6, 11.4) | 10.3 (9.3, 11.4) | |
| MHQ Appearance subscale (0–100), mean (95% CI) | 75.3 (73.0, 77.6) | 51.2 (45.4, 57.1) | 68.2 (64.9, 71.6) | 70.2 (65.7, 74.6) | 75.3 (72.5, 78.1) | 69.1 (64.4, 73.8) | 66.4 (60.7, 72.1) |
Analysis was completed on CASHA and CASK study participants using mutually exclusive subsets as determined in Fig. 1; Data are marginal means and 95% CIs estimated from the ANOVA model.
Individuals in this sub-group are symptomatic with pain in the last month and may have some radiographic changes, but they do not meet the criteria for any of the hand OA subsets. AUSCAN, Australian/Canadian Osteoarthritis Hand Index; data was missing for the following characteristics: AUSCAN Pain n = 130 (12.1%), AUSCAN Function n = 121 (11.2%), grip strength n = 10 (0.9%), pinch strength n = 20 (1.9%) and MHQ Appearance subscale n = 164 (15.2%).
Clinical characteristics at 3-years for subsets of symptomatic hand OA (n = 963)
| Unclassified | Erosive OA | Generalised hand OA | IPJ and thumb base OA | Thumb base OA | Nodal IPJ OA | Non-nodal IPJ OA | Difference between the groups (ANCOVA) significance | |
|---|---|---|---|---|---|---|---|---|
| Crude baseline mean score (95% CI) | 6.3 (5.8, 6.8) | 8.0 (6.7, 9.2) | 6.8 (6.2, 7.5) | 6.3 (5.4, 7.2) | 6.6 (6.0, 7.2) | 7.2 (6.2, 8.2) | 6.8 (5.6, 7.9) | |
| Crude 3-years mean score (95% CI) | 6.2 (5.7, 6.7) | 8.9 (7.4, 10.3) | 7.6 (6.9, 8.4) | 7.5 (6.5, 8.5) | 7.1 (6.5, 7.8) | 8.3 (7.2, 9.4) | 7.2 (5.9, 8.5) | |
| Adjusted 3-years mean score (95% CI) | 6.6 (6.1, 7.0) | 8.0 (6.8, 9.2) | 7.7 (7.0, 8.3) | 8.0 (7.1, 8.8) | 7.1 (6.6, 7.7) | 8.0 (7.1, 8.9) | 7.4 (6.3, 8.5) | |
| Crude baseline mean score (95% CI) | 9.3 (8.4, 10.2) | 13.5 (11.0, 15.9) | 11.1 (9.8, 12.5) | 9.9 (8.1, 11.7) | 10.6 (9.5, 11.8) | 10.8 (8.9, 12.7) | 10.0 (7.8, 12.2) | |
| Crude 3-years mean score (95% CI) | 9.5 (8.5, 10.4) | 16.5 (13.8, 19.2) | 12.2 (10.7, 13.6) | 11.6 (9.7, 13.5) | 11.5 (10.3, 12.8) | 12.5 (10.5, 14.5) | 10.8 (7.8, 12.2) | |
| Adjusted 3-years mean score (95% CI) | 10.6 (10.0, 11.3) | 13.9 (12.1, 15.6) | 11.9 (10.9, 12.9) | 12.6 (11.2, 13.9) | 11.3 (10.5, 12.2) | 12.3 (10.9, 13.6) | 11.4 (9.7, 13.0) | |
Analysis was completed on CASHA and CASK study participants using mutually exclusive subsets as determined in Fig. 1; Data are marginal means and 95% CI estimated from the ANCOVA model, baseline mean scores in this table differ from those in Table IV as these are for the individuals who were followed-up at 3-years.
Individuals in this sub-group are symptomatic with pain in the last month and may have some radiographic changes, but they do not meet the criteria for any of the hand OA subsets.
Adjusted for baseline score; ANCOVA, Analysis of covariance; Data was missing for the following characteristics: AUSCAN Pain at baseline n = 117 (12.1%), AUSCAN Pain at 3-years n = 156 (16.2%), AUSCAN Function at baseline n = 1078 (11.1%) and AUSCAN Function at 3-years n = 146 (15.2%).
Comparison of population prevalence estimates of hand OA subsets from different studies
| Population | Erosive OA | Thumb base OA | |||||||
|---|---|---|---|---|---|---|---|---|---|
| North Staffordshire, UK | Rotterdam, Netherlands | Framingham, USA | North Staffordshire, UK | Rotterdam, Netherlands | Copenhagen, Denmark | Zoetermeer, Netherlands | National, Finland | Hizen-Oshima, Japan | |
| 55–64 | – | 1.8 | – | – | 23.5 | – | – | – | – |
| 65–74 | – | 3.8 | – | – | 45.2 | – | – | – | – |
| 75–84 | – | 3.4 | – | – | 55.1 | – | – | – | – |
| 85+ | – | 3.6 | – | – | 51.9 | – | – | – | – |
| All ages | 1.0% (50+) | 2.8% (55+) | – | 22.4% (50+) | 35.8% (55+) | – | – | – | – |
| 50–54 | – | – | 0 | 9.8% | – | 0.8 | 11.5 | – | – |
| 55–59 | – | – | 2.0 | 11.3% | – | 1.3 | 15.5 | 10.5 | |
| 60–64 | – | – | 2.0 | 16.8% | – | 2.6 | 20.8 | – | |
| 65–69 | 0.6% | – | 4.0 | 18.8% | – | 5.8 | 18.1 | 13.0 | |
| 70–74 | – | – | 10.0 | 21.6% | – | 9.6 | 23.5 | – | |
| 75–79 | – | – | 8.0 | 21.8% | – | 11.4 | 42.4 | 26.5 | |
| 80+ | – | – | 28.0 | 27.4% | – | 22.7 | 25.9 | – | |
| All ages | 0.3% (50+) | – | 3.6 (28+) | 16.7% (50+) | – | 4.0 (40+) | – | 7.0 (30+) | – |
| 50–54 | 0.9% | – | 1.0 | 16.2% | – | 0 | 16.4 | – | 3.4 |
| 55–59 | 1.1% | – | 4.0 | 21.7% | – | 0 | 24.5 | 16.0 | |
| 60–64 | 1.5% | – | 11.0 | 24.7% | – | 4.5 | 34.5 | 7.0 | |
| 65–69 | 1.8% | – | 12.0 | 30.0% | – | 9.3 | 42.1 | 31.0 | |
| 70–74 | 3.2% | – | 30.0 | 34.4% | – | 15.2 | 46.7 | 20.5 | |
| 75–79 | 2.4% | – | 28.0 | 36.7% | – | 33.0 | 53.0 | 38.0 | |
| 80+ | 2.2% | – | 51.0 | 39.8% | – | 36.9 | 57.0 | 25.0 | |
| All ages | 1.7% (50+) | – | 9.8 (28+) | 27.4% (50+) | – | 7.4 (40+) | – | 15.0 (30+) | 10.2 (40+) |
Figures in brackets for all ages are the minimum age for each of the study populations.
Estimated from graphs provided in the publication.